Details of the Drug

General Information of Drug (ID: DMIO289)

Drug Name
TPIV 110
Indication
Disease Entry ICD 11 Status REF
Breast cancer 2C60-2C65 Phase 1 [1]
Cross-matching ID
TTD ID
D0W9MJ

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)